Position in AZN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$7,251,258
+$1,088,331 QoQ
Shares Held
38,241
+22.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#340
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Naviter Wealth, LLC holds $52,110,341 across 11 Drug Manufacturers - General names. AZN ranks #3 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,109 | $13,324,468 | |
| 2 | NVS |
Novartis AG
|
47,793 | $7,490,118 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
38,241 | $7,251,258 | |
| 4 | JNJ |
Johnson & Johnson
|
25,011 | $6,352,043 | |
| 5 | ABBV |
AbbVie Inc.
|
21,065 | $5,300,796 | |
| 6 | MRK |
Merck & Co., Inc.
|
24,004 | $3,084,514 | |
| 7 | GSK |
GSK plc
|
55,331 | $2,900,451 | |
| 8 | AMGN |
Amgen Inc
|
7,878 | $2,852,781 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,251,258 | 38,241 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $6,162,927 | 31,249 | Shares | Sole | 2026-04-10 | |
| No filing history on record for this holder in this stock. | ||||||